@prefix jvr: . @prefix skos: . @prefix mesh: . @prefix owl: . @prefix dc: . @prefix xsd: . jvr:-BT300B3G-Q skos:prefLabel "cerebrospinal fluid (Qualifier)"@en, "liquide cérébrospinal (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-L6C0XPHT-4 skos:prefLabel "métabolisme (Qualificatif)"@fr, "metabolism (Qualifier)"@en ; a mesh:Qualifier, skos:Concept . jvr:-XV06LPML-W skos:prefLabel "urine (Qualifier)"@en, "urine (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-Q3979798-W skos:prefLabel "analysis (Qualifier)"@en, "analyse (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-H7K65Q8S-Z skos:prefLabel "radiation effects (Qualifier)"@en, "effets des radiations (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-TJHVZCRZ-0 skos:prefLabel "administration et posologie (Qualificatif)"@fr, "administration & dosage (Qualifier)"@en ; a mesh:Qualifier, skos:Concept . jvr:-G30ZJ446-J skos:prefLabel "toxicity (Qualifier)"@en, "toxicité (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-NFTHND7Q-8 skos:prefLabel "intoxication (Qualificatif)"@fr, "poisoning (Qualifier)"@en ; a mesh:Qualifier, skos:Concept . jvr:-FMGCJXSP-1 skos:prefLabel "Agents de déplétion en cystine"@fr, "Cystine Depleting Agents"@en ; a mesh:Descriptor, skos:Concept . jvr:-FWD2BGQ0-9 skos:prefLabel "usage thérapeutique (Qualificatif)"@fr, "therapeutic use (Qualifier)"@en ; a mesh:Qualifier, skos:Concept . jvr:-THHNVC7V-3 skos:prefLabel "synthèse chimique (Qualificatif)"@fr, "chemical synthesis (Qualifier)"@en ; a mesh:Qualifier, skos:Concept . jvr:-R0ZCQ8X6-J skos:prefLabel "agonistes (Qualificatif)"@fr, "agonists (Qualifier)"@en ; a mesh:Qualifier, skos:Concept . jvr:-S0CS1X5R-5 skos:prefLabel "immunology (Qualifier)"@en, "immunologie (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-M63HSDM7-1 skos:prefLabel "antagonists & inhibitors (Qualifier)"@en, "antagonistes et inhibiteurs (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-HQRFT0C6-B skos:prefLabel "isolement et purification (Qualificatif)"@fr, "isolation & purification (Qualifier)"@en ; a mesh:Qualifier, skos:Concept . jvr:-NB0XHT3S-N skos:prefLabel "adverse effects (Qualifier)"@en, "effets indésirables (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-W6SQV79N-S skos:prefLabel "classification (Qualifier)"@en, "classification (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-CB30NGKB-3 skos:prefLabel "economics (Qualifier)"@en, "économie (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-G4R176S9-J skos:prefLabel "analogs & derivatives (Qualifier)"@en, "analogues et dérivés (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr: a skos:ConceptScheme . jvr:-SBNWSM1T-R skos:prefLabel "history (Qualifier)"@en, "histoire (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-J4DNNQ50-K skos:prefLabel "Aminoéthanethiols"@fr, "Mercaptoethylamines"@en ; a mesh:Descriptor, skos:Concept ; skos:narrower jvr:-D408MNF1-6 . jvr:-D408MNF1-6 owl:sameAs ; skos:hiddenLabel "Bromhydrate de mercaptamine"@fr, "Becaptan"@en, "Cysteamine, 35S-Labeled"@en, "Cysteamine Hydrochloride"@en, "Cysteamine Tosylate"@en, "Cysteamine Tartrate (1:1)"@en, "Tosilate de mercaptamine"@fr, "Cysteamine Dihydrochloride"@en, "Chlorhydrate de mercaptamine"@fr, "Cysteamine Bitartrate"@en, "Cysteamine Maleate (1:1)"@en, "Cystagon"@en, "Cysteamine Hydrobromide"@en, "Bitartrate de mercaptamine"@fr, "Mercaptamine (35S)"@fr, "Cysteamine Tartrate"@en, "Tosylate de mercaptamine"@fr ; skos:altLabel "Cystéamine"@fr, "55707-28-3 (35S-labeled)"@fr, "55707-28-3 (35S-labeled)"@en, "Mercaptamine"@en, "Cysteinamine"@en, "60-23-1 (Cysteamine)"@fr, "60-23-1 (Cysteamine)"@en, "Mercaptoethylamine"@en, "156-57-0 (HCl)"@fr, "156-57-0 (HCl)"@en, "16904-32-8 (di-HCl)"@fr, "16904-32-8 (di-HCl)"@en, "Ethanethiol, 2-amino-"@fr, "Ethanethiol, 2-amino-"@en, "93965-19-6 (maleate (1:1))"@fr, "93965-19-6 (maleate (1:1))"@en, "3037-04-5 (tosylate)"@fr, "3037-04-5 (tosylate)"@en, "5UX2SD1KE2"@en, "5UX2SD1KE2"@fr, "42954-15-4 (HBr)"@fr, "42954-15-4 (HBr)"@en, "IF1B771SVB"@fr, "IF1B771SVB"@en, "beta-Mercaptoethylamine"@en, "QO84GZ3TST"@fr, "QO84GZ3TST"@en, "Mercamine"@fr, "Mercamine"@en, "2-Aminoethanethiol"@en ; mesh:allowableQualifier jvr:-WK5F724J-1, jvr:-CB30NGKB-3, jvr:-Q3979798-W, jvr:-G4R176S9-J, jvr:-BT300B3G-Q, jvr:-NB0XHT3S-N, jvr:-S0CS1X5R-5, jvr:-L6C0XPHT-4, jvr:-R3QWLHRG-V, jvr:-M63HSDM7-1, jvr:-SBNWSM1T-R, jvr:-R0ZCQ8X6-J, jvr:-D0F21513-5, jvr:-T9HQD7ST-J, jvr:-G30ZJ446-J, jvr:-TJHVZCRZ-0, jvr:-NFTHND7Q-8, jvr:-H7K65Q8S-Z, jvr:-HQRFT0C6-B, jvr:-NKM836P1-M, jvr:-NHL3D2X0-S, jvr:-FWD2BGQ0-9, jvr:-XV06LPML-W, jvr:-W6SQV79N-S, jvr:-THHNVC7V-3 ; dc:modified "2014-06-12"^^xsd:date ; skos:inScheme jvr: ; dc:created "1999-01-01"^^xsd:date ; dc:established "1966-01-01"^^xsd:date ; a mesh:Descriptor, skos:Concept ; skos:definition "A mercaptoethylamine compound that is endogenously derived from the COENZYME A degradative pathway. The fact that cysteamine is readily transported into LYSOSOMES where it reacts with CYSTINE to form cysteine-cysteamine disulfide and CYSTEINE has led to its use in CYSTINE DEPLETING AGENTS for the treatment of CYSTINOSIS."@en ; skos:prefLabel "Cysteamine"@en, "Mercaptamine"@fr ; mesh:pharmacologicalAction jvr:-FMGCJXSP-1 ; skos:broader jvr:-J4DNNQ50-K . jvr:-D0F21513-5 skos:prefLabel "chemistry (Qualifier)"@en, "composition chimique (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-R3QWLHRG-V skos:prefLabel "standards (Qualifier)"@en, "normes (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-NHL3D2X0-S skos:prefLabel "sang (Qualificatif)"@fr, "blood (Qualifier)"@en ; a mesh:Qualifier, skos:Concept . jvr:-T9HQD7ST-J skos:prefLabel "ressources et distribution (Qualificatif)"@fr, "supply & distribution (Qualifier)"@en ; a mesh:Qualifier, skos:Concept . jvr:-NKM836P1-M skos:prefLabel "pharmacology (Qualifier)"@en, "pharmacologie (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-WK5F724J-1 skos:prefLabel "pharmacokinetics (Qualifier)"@en, "pharmacocinétique (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept .